BioLineRx Ltd. Logo

BioLineRx Ltd.

Biopharma firm developing and commercializing therapies for cancer and rare diseases.

BLRX | TA

Overview

Corporate Details

ISIN(s):
US09071M2052 (+1 more)
LEI:
529900AKIOSC15Y63R18
Country:
Israel
Address:
Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioLineRx Ltd. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapeutics for patients with specific cancers and rare diseases. The company leverages its comprehensive expertise to advance novel drug candidates through the entire development lifecycle, from preclinical research and clinical trials to regulatory approval and marketing. BioLineRx manages its own pipeline of therapies and also serves as a strategic partner for other drug developers, helping to advance promising early-stage compounds. The company's goal is to deliver meaningful and life-changing treatments that address significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 16:02
Foreign Filer Report
BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a …
English 368.6 KB
2025-09-29 16:02
Foreign Filer Report
BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a …
English 36.6 KB
2025-08-14 16:01
Earnings Release
Second Quarter 2025 Financial Results and Provides Corporate Update
English 375.7 KB
2025-08-14 16:01
Foreign Filer Report
Second Quarter 2025 Financial Results and Provides Corporate Update
English 36.5 KB
2025-07-26 23:19
Prospectus
Immediate Report
English 397.4 KB
2025-07-26 23:19
Prospectus
Immediate Report
English 36.3 KB
2025-07-01 01:25
Foreign Filer Report
Immediate Report
English 127.3 KB
2025-07-01 01:25
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-05-30 17:23
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
English 153.1 KB
2025-05-30 17:23
Foreign Filer Report
New Pilot Phase Data from Phase 2 Combination Trial of Motixafortide in First-L…
English 36.4 KB
2025-05-27 16:01
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
English 430.8 KB
2025-05-27 16:01
Foreign Filer Report
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate U…
English 36.4 KB
2025-05-24 23:14
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 160.1 KB
2025-05-24 23:14
Foreign Filer Report
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 534.4 KB
2025-05-24 23:14
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 29,2025,proxy statement
English 100.8 KB

Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DaehanPharmaceutical Logo
Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.
South Korea 023910
Daesung Microbiological Labs. Co. Ltd Logo
Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.
South Korea 036480
DAEWOONG PHARMA Logo
A global R&D partner for drug development, manufacturing, and commercialization services.
South Korea 069620
DAIICHI SANKYO COMPANY, LIMITED Logo
A global pharmaceutical firm developing novel therapies with a focus on oncology and ADCs.
Japan 4568
Daito Pharmaceutical Co., Ltd. Logo
Manufactures APIs, generic drugs, and health foods; provides contract manufacturing services.
Japan 4577
D&D Pharmatech Inc. Logo
Develops oral & injectable peptide therapies for metabolic & chronic diseases like obesity.
South Korea 347850
Dechra Pharmaceuticals PLC Logo
Develops & sells veterinary pharmaceuticals for companion animals, exclusively to veterinarians.
United Kingdom DPH
Dermapharm Holding SE Logo
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
Germany DMP
Deutsche Biotech Innovativ AG Logo
Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.
Germany DBI
DEVA HOLDİNG A.Ş. Logo
Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.
Spain DEVA

Talk to a Data Expert

Have a question? We'll get back to you promptly.